Anti-BCMA CAR T Cells are a BCMA targeted CAR T Cell therapy being developed at the National Cancer Institute.
SparkCures ID | 127 |
---|---|
Generic Name | Anti-BCMA CAR T Cells |
Treatment Classifications |
|
Treatment Targets |
View all active clinical trials around the US.
SparkCures Verified Accurate, up-to-date information. Learn more
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
SparkCures Verified Accurate, up-to-date information. Learn more
There are no resources, links or videos to display for this treatment.